Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Valery A Petrenko

Valery A Petrenko

Auburn University, USA

Title: Title: Discovery of host cell-binding sites in the hemagglutinin of influenza virus using polyvalent (‘landscape’) peptide phage-displayed library as a molecular adaptation system

Biography

Biography: Valery A Petrenko

Abstract

During natural evolution, viruses have evolved into molecular structures with optimized relationships with a host. In particular, viruses acquired surface peptides that allow them to attach to a host cells and invade into the cells through interaction with cellular receptors and co-receptors. Identification of these cell-recognition peptides would offer a strong basis for development of antiviral drugs, vaccines and diagnostics, prediction of viral drifts from one host to another and prediction and control of emergent infections. Bacteriophage Fd possesses no natural tropism to mammalian cells and is suitable as a vector for generating random peptide phage-displayed libraries. It was shown that phages selected from these libraries are able to specifically recognize cellular receptors and penetrate into sub-cellular compartments during their artificial molecular evolution in vitro, similarly to evolution observed with naturally evolved viruses. We hypothesized that selection of cell-associated phage variants from their multi-billion clone libraries and bioinformatic analysis of their cell-binding peptides in comparison with proteins of natural viruses would allow the elucidation of functional virus-host binding sites used during viral pathogenesis. To test our hypothesis, we enriched a subpopulation of phages that interact with human small airway epithelial (SAE) cells and identified the recovered sequences by next-generation sequencing. We then analyzed the phage sequence library against consensus sequences of representative viral proteins, such as hemagglutinin (HA) from different influenza strains over the past 6 years and 5 of the last major pandemics. Several families of peptides were identified with high structural homology to some previously recognized functional segments of HA in the mature viral particles. The identified regions were associated primarily with the membrane fusion peptide domain and the HA0 cleavage site. However other regions were identified suggesting identification of residues involved with a potential co-receptor binding site (CoRBS). The identified peptides revealed regions of HA that were not previously identified as a receptor binding site (RBS) or common antigenic region. Our findings justify the hypothesis that similar mechanisms of molecular adaptation are used in viruses to adjust HA proteins to mammalian cell receptors. After testing their immunological activity, the identified phage peptides can be used as lead compounds for construction of molecular and phage-based vaccines to protect the host from the corresponding virus.